Suffice it to Say, Pending Claims Are Irrelevant for Sufficiency 16 Aug 2022Aleem Abdulla The Federal Court of Appeal clarified in Pharmascience v. Bristol-Myers Squibb, 2022 FCA 142, that the specification of the issued patent, not... Read More
